Foxy-5

N/A

Report date: 2022/10/21 15:47:22
NME

Base Information

Drug NameFoxy-5
Drug Alias NameFoxy-5Foxy-5 ((WNT5A)-mimicking peptide)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionWnt signalling pathway stimulantsProtein Wnt-5a agonists
TargetsProtein Wnt-5a
Therapy Area/IndicationsMetastatic breast cancerProstatic NeoplasmsColonic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWntresearch Ab
China Registration ClassN/A

Develop Information

Active CompaniesWntresearch Ab
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsMetastatic breast cancerProstatic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A